Category Archives: biotech

Long-time DR sufferers are already familiar with our friend and colleague Dr. Marc Faber – author of The Gloom, Boom and Doom Report, and one of the foremost contrarian economists working today. Well, we’ve secured an exclusive interview with Dr. Faber – hosted by our own Dan Mangru – which will premier on Tuesday, November 24th…Read more…

Today the House Finance Committee approved the Ron Paul and Jim DeMint amendment to audit the Federal Reserve. It’s a step in the right direction, but the amendment still has some way to go before it sees the light of day. To build momentum, Paul and DeMint have written their opinion in the Wall Street…Read more…

It’s pretty clear that without tungsten, a lot of things in this world will — literally — grind to a halt. Now let’s ask, where’s the world’s tungsten? Here’s a recent pie chart of world tungsten reserves. In addition to its large reserve base (57%), China presently controls about 75% of the world’s output of tungsten. Characteristically,…Read more…

What happened yesterday? The Dow sold off 93 points. Investors had been hesitating. There’s supposed to be a recovery going on. But the latest news is unsettling. Housing and employment numbers are weak. What’s going on? Maybe this recovery is not a sure thing after all. “Record numbers late on US loans,” says a headline in…Read more…